Exondys 51, 500 MG in 10 ML Injection
- RxCUI
- 1810582
- RxNorm name
- Exondys 51, 500 MG in 10 ML Injection
- Display name
- Exondys 51, 500 MG in 10 ML Injection
- Full name
- Exondys 51, 500 MG in 10 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:53
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Exondys 51 | ETEPLIRSEN | Sarepta Therapeutics, Inc. | 33bff678-7829-479e-9110-b8e33a0bc0aa | 2025-08-13 | Warnings, Adverse reactions | 1810582 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 33bff678-7829-479e-9110-b8e33a0bc0aa | Exondys 51, 500 MG in 10 ML Injection [PSN] · 10 ML eteplirsen 50 MG/ML Injection [Exondys] [SBD] · 10 ML Exondys 50 MG/ML Injection [SY] · Exondys 500 MG per 10 ML Injection [SY] | 4 | 15 | These highlights do not include all the information needed to use EXONDYS 51 ® safely and effectively. See full prescribing information for EXONDYS 51. EXONDYS 51 (eteplirsen) injection, for intravenous use Initial U.S. Approval: 2016 | 20250813 |